New mechanism that permits selective capture of microRNAs in nanovesicles that shuttle between cells

Dec 20, 2013

A team of CNIC researchers directed by Prof. Francisco Sánchez-Madrid (Universidad Autónoma de Madrid & CNIC) has described for the first time how microRNAs— small RNA molecules that regulate the expression of specific genes—are encapsulated in nanovesicles that shuttle between cells.

The role of microRNAs (miRNAs) is fundamental for the correct moment-to-moment adjustment in the expression of . "Before this study, we already knew that these small molecules could be packaged into small vesicles and exported to the extracellular space, to be later captured by other cells and in this way play an important role in intercellular communication," explains CNIC researcher Carolina Villarroya, the first author on the study.

What was not known until now was the mechanism by which miRNAs are encapsulated and exported. And this is precisely what graduate researcher Villarroya and Dr. María Mittelbrunn—from Prof. Sánchez Madrid's group—have discovered, working closely with Dr. Fátima Sánchez Cabo of the Bioinformatics Unit and Dr. Jesús Vázquez of the Proteomics Unit.

The article describes how a specific group of miRNAs that are actively exported in nanovesicles from human T lymphocytes share specific nucleotide sequence patterns called EXOmotifs. When these EXOmotifs are mutated, export of these miRNAs is impeded; and when they are introduced into other miRNAs, export is facilitated. EXOmotifs provide the binding site for a protein called hnRNPA2B1, which is responsible for transporting miRNAs to the interior of nanovesicles.

hnRNPA2B1 is also implicated in the transport of the genomic RNA of viruses such as HIV to sites of exit to the cell exterior. This establishes a parallel between the secretion of vesicles loaded with RNA and the production of viruses that parasitize the cellular machinery to extend infection.

The discovery suggests a new route for packaging RNA molecules of interest into nanovesicles, which have enormous potential as vehicles for gene therapy, vaccines and antitumor treatments. These findings form the basis of a new patent by the researchers and their institutions the CNIC and the UAM.

The results of the study has been published in Nature Communications.

Explore further: NYSCF Research Institute announces largest-ever stem cell repository

add to favorites email to friend print save as pdf

Related Stories

New fluorescent tools for cancer diagnosis

May 24, 2013

In recent years, microRNAs (miRNAs) and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers. miRNA profiles have been used ...

Study links 23 microRNAs to laryngeal cancer

Sep 13, 2011

A Henry Ford Hospital study has identified 23 microRNAs for laryngeal cancer, a discovery that could yield new insight into what causes certain cells to grow and become cancerous tumors in the voice box.

Molecular switch affects panic disorder

Apr 15, 2011

Panic disorder sufferers will tell you the attacks are some of the most sudden, frightening and uncomfortable experiences ever. But what makes some people susceptible to these attacks and others not? Studies of twins point ...

Recommended for you

Crowdsourced power to solve microbe mysteries

23 hours ago

University of New South Wales scientists hope to unlock the secrets of millions of marine microbes from waters as far apart as Sydney's Botany Bay and the Amazon River in Brazil, with the help of an international ...

Reading a biological clock in the dark

Oct 21, 2014

Our species' waking and sleeping cycles – shaped in millions of years of evolution – have been turned upside down within a single century with the advent of electric lighting and airplanes. As a result, ...

User comments : 0